Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Deals are abound!!!!

<< Previous

Bullboard Posts

Next >>

Post by fox7mfon Aug 05, 2022 9:47am

258 Views

Post# 34873725

Deals are abound!!!!

Biotechs are getting bought up at what seems like a weekly rate. Many post about these acquisitions here, suggesting they have to be good news for Onc. But...how much will BP spend before they've spent enough, and will Onc have a deal when it's over? I'm confident in the science...confident in the Parsons addition.. but I continue to worry that Coffey might be asking for too much.

<< Previous

Bullboard Posts

Next >>

The deep connection between mining and First Nations in Canada